Nurse Practitioner, Family · Hampton, VA
NPI
1457776684
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2315 W Mercury Blvd # Va007
Hampton, VA, 23666
Phone (866) 389-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,616
152 services
Medicare patients, 2024
118
Average age 73
Drug cost, 2024
$1.6M
3,097 prescriptions
Company payments, 2025
$3,739
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley Foreman was code 99214 (office e&m - established), 97 times for 91 patients. In total Ashley Foreman billed 152 services in 10 codes, and Medicare paid $9,616.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 97 | 91 | $67.13 | $6,512 |
| 99204 Office E&M - New | Office | 20 | 20 | $97.01 | $1,940 |
By year: 2022 $21K for 313 services; 2023 $14K for 178 services; 2024 $9,616 for 152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashley Foreman prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 486 prescriptions and refills. In total Ashley Foreman wrote 3,097 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 486 | 607 | 119 | $381K |
| Prednisone Generic | 323 | 406 | 154 | $1,110 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 320 | 382 | 127 | $8,050 |
| Montelukast Sodium Generic | 177 | 467 | 64 | $1,930 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 125 | 151 | 39 | $93K |
| Breo Ellipta Fluticasone/Vilanterol | 98 | 122 | 24 | $46K |
| Spiriva Respimat Tiotropium Bromide | 98 | 132 | 29 | $68K |
| Eszopiclone Generic | 96 | 102 | 21 | $1,637 |
| Tezspire Tezepelumab-Ekko | 96 | 96 | 16 | $410K |
| Azithromycin Generic | 90 | 102 | 53 | $457 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 61 | 103 | 20 | $9,270 |
| Roflumilast Generic | 59 | 69 | 12 | $3,449 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 57 | 65 | 18 | $7,329 |
| Symbicort Budesonide/Formoterol Fumarate | 43 | 63 | 20 | $14K |
| Fluticasone Propionate Generic | 42 | 91 | 17 | $318 |
Brand drugs: 1,461 claims; generic drugs: 1,636 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley Foreman $3,739 ($3,739 in general payments such as food, travel and fees) from 22 companies. The largest payer was GlaxoSmithKline, LLC. with $705.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 27 | $705 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $701 |
| Genzyme Corporation SNY | 9 | $330 |
| Amgen Inc. AMGN | 15 | $294 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $190 |
| Electromed, Inc. ELMD | 14 | $189 |
| Grifols USA, LLC | 6 | $185 |
| Verona Pharma, Inc. VRNA | 8 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.